This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SCHNEIDER, A. B. Articles by KUMA, K. Search for Related Content PubMed PubMed Citation Articles by SCHNEIDER, A. B. Articles by KUMA, K.

Iodine Content of Serum Thyroglobulin in Normal Individuals and Patients with Thyroid Tumors^*

Department of Medicine, Michael Reese Hospital, University of Chicago Chicago, Illinois 60616
Kobe Central Municipal Hospital and Kuma Hospital Kobe, Japan

Address all correspondence and requests for reprints to: Dr. Arthur B. Schneider, Michael Reese Hospital, Department of Medicine, Division of Endocrinology, Chicago, Illinois 60616.

We indirectly estimated the iodine content of serum thyroglobulin (TG) in normal individuals and patients with benign and malignant thyroid tumors. Because insufficient TG is present in the serum to perform chemical determinations, equilibrium density centrifugation was used to determine its density, a measure of TG iodine content. In five patients undergoing thyroidectomy, serum TG was compared to TG extracted from the nodules and TG from the surrounding normal thyroid tissue. The iodine content of the tumor TG was much less than that of normal TG in four of the five patients. In patients with benign and malignant nodules, the iodine content of serum TG was lower than that of normal TG, and it was similar in patients with benign and malignant disease. In normal individuals, serum TG was also poor in iodine, similar to the serum TG from the patients, and in the same position as TG with virtually no iodine. These findings are in accord with our report that serum TG in rats is nearly completely devoid of iodine.

TG could enter the circulation either by secretion of newly synthesized TG or release of stored TG from the thyroid. The findings show that serum TG in normal individuals does not result from the release of preexisting TG. More likely, it arises from the secretion of poorly iodinated, newly synthesized molecules. Since the elevated serum TG found in patients with nodules also is poor in iodine, it must come directly from the tumor rather than from destruction of surrounding normal thyroid tissue.

^* This work was supported in part by USPHS NCI Grant R01-CA-21518.

Received March 17, 1983.

This article has been cited by other articles:

				C. A. Spencer, L. M. Bergoglio, M. Kazarosyan, S. Fatemi, and J. S. LoPresti Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5566 - 5575. [Abstract] [Full Text] [PDF]

				Y. D. Dai, V. P. Rao, and G. Carayanniotis Enhanced Iodination of Thyroglobulin Facilitates Processing and Presentation of a Cryptic Pathogenic Peptide J. Immunol., June 1, 2002; 168(11): 5907 - 5911. [Abstract] [Full Text] [PDF]

				C. A. Spencer, M. Takeuchi, M. Kazarosyan, C. C. Wang, R. B. Guttler, P. A. Singer, S. Fatemi, J. S. LoPresti, and J. T. Nicoloff Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1121 - 1127. [Abstract] [Full Text]

				S. Benvenga, L. Bartolone, S. Squadrito, and F. Trimarchi Thyroid Hormone Autoantibodies Elicited by Diagnostic Fine Needle Biopsy J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4217 - 4223. [Abstract] [Full Text] [PDF]